⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

July 12, 2021Clinical Oral InvestigationsOpen Access

Salivary IL-8 as a putative predictive biomarker of radiotherapy response in head and neck cancer patients

Sara Principe Enrique Zapater-Latorre Leo Arribas E. García-Miragall José Vicente Bagán Sebastián

View Full Paper

Ask AI

Bookmark

Share

Abstract

Salivary IL-8 expression in HNC patients undergoing RT may serve as a potential predictive biomarker of response to the treatment.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Principe et al. (2021) studied this question.

synapsesocial.com/papers/69df3db035659245ec6142e3 https://doi.org/10.1007/s00784-021-04017-0

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Head and neck cancer: improving outcomes with a multidisciplinary approachReview · 2017 · 246 citations
2Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries2018 · 83,937 citations
3Changes in Survival in Head and Neck Cancers in the Late 20th and Early 21st Century: A Period AnalysisOriginal Research · 2010 · 849 citations
4Salivary Immunosuppressive Cytokines IL-10 and IL-13 Are Significantly Elevated in Oral Squamous Cell Carcinoma PatientsCross-Sectional Study · 2015 · 100 citations
5Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathwaysReview · 2009 · 657 citations

More related papers

The Clinical Usefulness of the Measurement of Cytokines2000
Mucositis2015
The feasibility of monitoring NF‐κB associated cytokines: TNF‐α, IL‐1α, IL‐6, and IL‐8 in whole saliva for the malignant transformation of oral lichen planus2005

More from Clinical Oral Investigations

Impact of different post-polymerization protocols on fracture load and two-body wear of 3D-printed fixed dental prosthesesThu,
Demographic characteristics and comorbidities in patients with oral mucous membrane pemphigoid and pemphigusWed,